Related Experiment Video
Updated: Aug 2, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
SARS-CoV-2 Infection and COVID-19 in Children
Alpana Waghmare1, Diego R Hijano2
1Department of Pediatrics, University of Washington, Fred Hutchinson Cancer Research Center Vaccine, 1100 Fairview Avenue North, Seattle, WA 98109, USA; Department of Infectious Diseases, Division Seattle Children's Hospital, Seattle, WA, USA.
Insights
Most children experience mild or no symptoms from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). However, some children may develop severe disease or multisystem inflammatory syndrome in children (MIS-C).
Area of Science:
- Pediatrics
- Infectious Diseases
- Virology
Background:
- Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a prevalent infection among pediatric populations.
- Clinical presentations of SARS-CoV-2 in children range from asymptomatic to severe disease.
- Risk factors such as age and underlying health conditions influence disease severity.
Purpose of the Study:
- To provide a comprehensive overview of the clinical manifestations of coronavirus disease 2019 (COVID-19) in children.
- To discuss the post-infectious complication, multisystem inflammatory syndrome in children (MIS-C).
- To outline current treatment and prophylaxis strategies for pediatric COVID-19.
Main Methods:
- This article provides a narrative review of existing literature on pediatric SARS-CoV-2 infections.
- It synthesizes information on clinical presentations, risk factors, and outcomes.
- Current therapeutic and preventive measures are discussed based on available evidence.
Main Results:
- The majority of children infected with SARS-CoV-2 exhibit mild or no symptoms.
- Certain pediatric groups are at higher risk for moderate to severe COVID-19.
- Multisystem inflammatory syndrome in children (MIS-C) is a significant post-infectious complication.
Conclusions:
- Understanding the varied clinical spectrum of COVID-19 in children is crucial for timely diagnosis and management.
- Early identification of high-risk children and prompt intervention are essential.
- Ongoing research into novel therapeutics and prophylaxis is vital given the evolving landscape of SARS-CoV-2 infection.
Abstract:
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is common in children, and clinical manifestations can vary depending on age, underlying disease, and vaccination status. Most children will have asymptomatic or mild infection, but certain baseline characteristics can increase the risk of moderate to severe disease. The following article will provide an overview of the clinical manifestations of coronavirus disease 2019 in children, including the post-infectious phenomenon called multisystem inflammatory syndrome in children. Currently available treatment and prophylaxis strategies will be outlined, with the caveat that new therapeutics and clinical efficacy data are constantly on the horizon.
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
10:25Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Viral Recombination
Single Nucleotide Polymorphisms-SNPs